HIV and tuberculosis

Globally, the health burdens of tuberculosis (TB) and HIV are extremely high. TB is the second highest cause of infectious-disease deaths (behind COVID-19) and is the leading cause of death for individuals with HIV. While progress in detection, treatment, and prevention has been improved for both, declines in incidence are not at the levels required to end them as major public health threats. To help accelerate incidence declines, research teams at IDM focus on developing and applying advanced modeling techniques for epidemic modeling, data analysis, and genomic epidemiology. Our models are used to design and optimize interventions, such as new vaccines, diagnostics, and innovative prevention approaches targeting upstream determinants of high-risk groups (such as nutrition and housing for TB or addressing heterogeneity in HIV risk). We collaborate with global, academic, and in-country partners to translate research into actionable outcomes.  

The Desmond Tutu HIV Foundation Research Site in Masiphumelele on the South Peninsula of Cape Town, South Africa on February 7, 2020.